Biomarkers in ovarian cancer: To be or not to be

被引：39
|
作者：
Arend, Rebecca [1 ]
Martinez, Alba [1 ]
Szul, Tomasz [1 ]
Birrer, Michael J. [1 ]
机构：
[1] Univ Alabama Birmingham, 619 19th St S,176F 10390E, Birmingham, AL 35249 USA
来源：
CANCER | 2019年 / 125卷
关键词：
biomarkers; genomics; molecular signatures; ovarian cancer; targeted therapy; HOMOLOGOUS RECOMBINATION GENES; NEOADJUVANT CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; CARCINOMA; SURVIVAL; MUTATIONS; PATTERNS; SUBTYPES; THERAPY; REPAIR;
D O I：
10.1002/cncr.32595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Biomarkers are becoming increasingly important in the treatment of epithelial ovarian cancer. Recent work from many laboratories has begun to provide clinically meaningful biomarkers. This review summarizes the state of the science regarding biomarkers for stratifying early-stage patients into those who benefit from adjuvant treatment, primary debulking versus interval debulking, and specific targeted therapy. In addition, new molecular imaging technologies have been developed to allow the surgeon to resect subvisible tumor deposits. These efforts should increase clinical effectiveness while minimizing toxicities for patients.
引用
收藏
页码：4563 / 4572
页数：10
相关论文
共 50 条
  • [31] Searching for a system: The quest for ovarian cancer biomarkers
    Rodland, Karin D.
    Maihle, Nita J.
    CANCER BIOMARKERS, 2010, 8 (4-5) : 223 - 230
  • [32] Current state of biomarkers in ovarian cancer prognosis
    Au, Katrina K.
    Josahkian, Juliana A.
    Francis, Julie-Ann
    Squire, Jeremy A.
    Koti, Madhuri
    FUTURE ONCOLOGY, 2015, 11 (23) : 3187 - 3195
  • [33] Serum biomarkers for early detection of ovarian cancer
    Meinhold-Heerlein, I.
    Braeutigam, K.
    Bauerschlag, D. O.
    Maass, N.
    Arnold, N.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (08) : 830 - 837
  • [34] Identification and Analysis of Gene Biomarkers for Ovarian Cancer
    Wang, Xiaodan
    Xie, Chengmao
    Lu, Chang
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2024, 28 (02) : 70 - 81
  • [35] Prognostic DNA methylation biomarkers in ovarian cancer
    Wei, SH
    Balch, C
    Paik, HH
    Kim, YS
    Baldwin, RL
    Liyanarachchi, S
    Li, L
    Wang, ZL
    Wan, JC
    Davuluri, RV
    Karlan, BY
    Gifford, G
    Brown, R
    Kim, S
    Huang, THM
    Nephew, KP
    CLINICAL CANCER RESEARCH, 2006, 12 (09) : 2788 - 2794
  • [36] A multiplex platform for the identification of ovarian cancer biomarkers
    Boylan, Kristin L. M.
    Geschwind, Kate
    Koopmeiners, Joseph S.
    Geller, Melissa A.
    Starr, Timothy K.
    Skubitz, Amy P. N.
    CLINICAL PROTEOMICS, 2017, 14
  • [37] GERMLINE GENES - A GOLDMINE FOR OVARIAN CANCER BIOMARKERS?
    Sammut, J.
    Feichtinger, J.
    McFarlane, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (08) : 25 - 25
  • [38] Molecular Biomarkers for the Early Detection of Ovarian Cancer
    Zhang, Ruiqian
    Siu, Michelle K. Y.
    Ngan, Hextan Y. S.
    Chan, Karen K. L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [39] Autoantibody biomarkers for the detection of serous ovarian cancer
    Katchman, Benjamin A.
    Chowell, Diego
    Wallstrom, Garrick
    Vitonis, Allison F.
    LaBaer, Joshua
    Cramer, Daniel W.
    Anderson, Karen S.
    GYNECOLOGIC ONCOLOGY, 2017, 146 (01) : 129 - 136
  • [40] AUTOANTIBODY BIOMARKERS FOR THE EARLY DETECTION OF OVARIAN CANCER
    Martin, K.
    Hoffmann, P.
    Oehler, M. K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 255 - 255
12345